Cargando…
Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing
OBJECTIVES: Our objective was to simulate the distribution of human papillomavirus (HPV) DNA test results from a 96-well microplate assay to identify results that may be consistent with well-to-well contamination, enabling programs to apply specific quality assurance parameters. MATERIALS AND METHOD...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023602/ https://www.ncbi.nlm.nih.gov/pubmed/29570137 http://dx.doi.org/10.1097/LGT.0000000000000391 |
_version_ | 1783335900952920064 |
---|---|
author | Beylerian, Emily N. Slavkovsky, Rose C. Holme, Francesca M. Jeronimo, Jose A. |
author_facet | Beylerian, Emily N. Slavkovsky, Rose C. Holme, Francesca M. Jeronimo, Jose A. |
author_sort | Beylerian, Emily N. |
collection | PubMed |
description | OBJECTIVES: Our objective was to simulate the distribution of human papillomavirus (HPV) DNA test results from a 96-well microplate assay to identify results that may be consistent with well-to-well contamination, enabling programs to apply specific quality assurance parameters. MATERIALS AND METHODS: For this modeling study, we designed an algorithm that generated the analysis population of 900,000 to simulate the results of 10,000 microplate assays, assuming discrete HPV prevalences of 12%, 13%, 14%, 15%, and 16%. Using binomial draws, the algorithm created a vector of results for each prevalence and reassembled them into 96-well matrices for results distribution analysis of the number of positive cells and number and size of cell clusters (≥2 positive cells horizontally or vertically adjacent) per matrix. RESULTS: For simulation conditions of 12% and 16% HPV prevalence, 95% of the matrices displayed the following characteristics: 5 to 17 and 8 to 22 total positive cells, 0 to 4 and 0 to 5 positive cell clusters, and largest cluster sizes of up to 5 and up to 6 positive cells, respectively. CONCLUSIONS: Our results suggest that screening programs in regions with an oncogenic HPV prevalence of 12% to 16% can expect 5 to 22 positive results per microplate in approximately 95% of assays and 0 to 5 positive results clusters with no cluster larger than 6 positive results. Results consistently outside of these ranges deviate from what is statistically expected and could be the result of well-to-well contamination. Our results provide guidance that laboratories can use to identify microplates suspicious for well-to-well contamination, enabling improved quality assurance. |
format | Online Article Text |
id | pubmed-6023602 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-60236022018-07-11 Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing Beylerian, Emily N. Slavkovsky, Rose C. Holme, Francesca M. Jeronimo, Jose A. J Low Genit Tract Dis Original Research Articles: Cervix and HPV OBJECTIVES: Our objective was to simulate the distribution of human papillomavirus (HPV) DNA test results from a 96-well microplate assay to identify results that may be consistent with well-to-well contamination, enabling programs to apply specific quality assurance parameters. MATERIALS AND METHODS: For this modeling study, we designed an algorithm that generated the analysis population of 900,000 to simulate the results of 10,000 microplate assays, assuming discrete HPV prevalences of 12%, 13%, 14%, 15%, and 16%. Using binomial draws, the algorithm created a vector of results for each prevalence and reassembled them into 96-well matrices for results distribution analysis of the number of positive cells and number and size of cell clusters (≥2 positive cells horizontally or vertically adjacent) per matrix. RESULTS: For simulation conditions of 12% and 16% HPV prevalence, 95% of the matrices displayed the following characteristics: 5 to 17 and 8 to 22 total positive cells, 0 to 4 and 0 to 5 positive cell clusters, and largest cluster sizes of up to 5 and up to 6 positive cells, respectively. CONCLUSIONS: Our results suggest that screening programs in regions with an oncogenic HPV prevalence of 12% to 16% can expect 5 to 22 positive results per microplate in approximately 95% of assays and 0 to 5 positive results clusters with no cluster larger than 6 positive results. Results consistently outside of these ranges deviate from what is statistically expected and could be the result of well-to-well contamination. Our results provide guidance that laboratories can use to identify microplates suspicious for well-to-well contamination, enabling improved quality assurance. Lippincott Williams & Wilkins 2018-07 2018-05-04 /pmc/articles/PMC6023602/ /pubmed/29570137 http://dx.doi.org/10.1097/LGT.0000000000000391 Text en Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the ASCCP. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Articles: Cervix and HPV Beylerian, Emily N. Slavkovsky, Rose C. Holme, Francesca M. Jeronimo, Jose A. Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing |
title | Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing |
title_full | Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing |
title_fullStr | Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing |
title_full_unstemmed | Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing |
title_short | Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing |
title_sort | statistical modeling for quality assurance of human papillomavirus dna batch testing |
topic | Original Research Articles: Cervix and HPV |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023602/ https://www.ncbi.nlm.nih.gov/pubmed/29570137 http://dx.doi.org/10.1097/LGT.0000000000000391 |
work_keys_str_mv | AT beylerianemilyn statisticalmodelingforqualityassuranceofhumanpapillomavirusdnabatchtesting AT slavkovskyrosec statisticalmodelingforqualityassuranceofhumanpapillomavirusdnabatchtesting AT holmefrancescam statisticalmodelingforqualityassuranceofhumanpapillomavirusdnabatchtesting AT jeronimojosea statisticalmodelingforqualityassuranceofhumanpapillomavirusdnabatchtesting |